Peels

Peels is a biotechnology and wellness company that specialized in the production of bio-identical CBD derived from orange peels rather than hemp. Utilizing a proprietary process known as Cyclic Terpene Assembly (CTA), the company converted terpenes from citrus waste into pure cannabidiol that is molecularly identical to hemp-derived CBD but inherently free from THC and hemp-related impurities. This approach addressed regulatory and purity concerns associated with traditional hemp cultivation, such as heavy metal contamination and psychoactive trace elements. The company's product line included oils and gummies targeted at consumers seeking relief from anxiety, pain, and sleep issues. Although the company gained significant attention for its science-led alternative to traditional cannabinoids, it appears to have ceased active operations as of late 2022.